Treat
Could a Parkinson’s disease drug improve sleep and memory in Alzheimer’s?
Dr Jonathan Blackman at the University of Bristol is investigating how the Parkinson’s drug, Levodopa may improve sleep and memory in people with mild Alzheimer’s disease.
Phase 2 trial results show donanemab may slow decline in early Alzheimer’s
Data from a trial of the drug donanemab suggests the treatment may be able to slow decline in people with early Alzheimer’s disease.
Targeting tiny amyloid clumps in Alzheimer’s disease
Dementia researcher, Dr Alfonso De Simone will look to better understand the shape and structure of tiny clumps of amyloid during Alzheimer’s disease.
Is HDAC4 protein a potential drug target in Parkinson’s disease?
Researchers in Oxford are investigating a potential drug target, opening the door to a new treatment avenue for Parkinson’s disease.
Can drugs that boost noradrenaline improve memory?
Researchers will work with people who have early Alzheimer’s disease see if two drugs that boost noradrenaline will improve memory and concentration.
Targeting a key protein in Dementia with Lewy bodies and Parkinson’s disease
Researcher, Prof Jody Mason at the University of Bath will investigate the build-up of a key protein in the development of dementia with Lewy bodies.
Can a cannabis-derived medicine help with symptoms of agitation in dementia?
People living with dementia can experience a wide range of symptoms, affecting not only someone’s memory and thinking skills, but also their behaviour.
Assessing the biological consequences of a potential Alzheimer’s treatment
Researchers at the University of Southampton are studying the effects of blocking an overactive protein that contributes to the development of Alzheimer’s disease
Identifying targets to tackle brain inflammation
Researchers at King’s Collage London are investigating potential drugs to stop damaging inflammation in brain cells.
Researching the link between Alzheimer’s disease and diabetes
Researchers in Aberdeen are exploring the link between diabetes and Alzheimer’s disease
